08333 ASTRUM FIN
- 0.275
- 0.0000.00%
About ASTRUM FIN Company
We are a financial services provider in Hong Kong that provides (i) securities trading and brokerage services; (ii) placement and underwriting services; (iii) corporate finance advisory services; (iv) financing services, including securities and initial public offering financing; and (v) asset management services. All of our business activities are carried out through our operating subsidiary, AstraZeneca Capital, which is licensed to carry out regulated activities under the Securities and Futures Regulations under the Securities and Futures Regulations under Class 1 (trading securities), Class 2 (trading futures contracts), Type 6 (advising on institutional financing) and Type 9 (providing asset management). AstraZeneca Capital is also a stock exchange participant and currently holds a stock exchange trading right. We did not engage in futures contract trading or proprietary trading business during the track record period.
Company Profile
Company Executives
- Name
- Position
- Salary
- ji pan
- Presidencies, CEO, Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
- 2.78M
- zhenyi guan
- Executive Director, Nomination Committee Members, Remuneration Committee Members, Chief Inspector, Authorized Representative
- 1.94M
- kailing yu
- Executive Director
- 431.00K
- long shen
- Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members, Audit Committee Members
- 132.00K
- hanji liu
- Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
- 144.00K
- songshi yu
- Independent Non-Executive Director, Remuneration Committee Members, Nomination Committee Members, Audit Committee Members
- 132.00K
- daxiong feng
- Head of the Trading Department
- --
- yongtai lin
- Legal Process Agent, Company Secretary
- --
Analysis
Price Target
No Data
No Data